| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FLI1 IKZF3 GATA3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 PITX3 NKX2-5 ELK4 EBF4 ZNF292 CREB3L2 NOBOX | 1.25e-07 | 560 | 129 | 17 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FLI1 IKZF3 GATA3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 PITX3 NKX2-5 ELK4 EBF4 ZNF292 CREB3L2 NOBOX | 1.45e-07 | 566 | 129 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.89e-05 | 25 | 129 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.60e-05 | 27 | 129 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FLI1 IKZF3 FOXO6 GATA3 NPAS3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 DBX1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 CUX1 EBF4 ZNF292 CREB3L2 NOBOX | 3.38e-05 | 1412 | 129 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.24e-04 | 3 | 129 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FLI1 IKZF3 FOXO6 GATA3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 CUX1 EBF4 CREB3L2 NOBOX | 1.41e-04 | 1244 | 129 | 20 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FLI1 IKZF3 FOXO6 GATA3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 CUX1 EBF4 CREB3L2 NOBOX | 1.87e-04 | 1271 | 129 | 20 | GO:0000987 |
| GeneOntologyMolecularFunction | signal sequence binding | 3.28e-04 | 51 | 129 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FLI1 IKZF3 FOXO6 GATA3 NPAS3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 CUX1 EBF4 CREB3L2 NOBOX | 4.26e-04 | 1459 | 129 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | structural molecule activity | ANK2 ANK3 IMPG1 MAP4 NUP98 DAG1 NUP214 MAP7 POM121 MUC17 VCAN BSN POM121B MUC2 MYBPC1 | 6.41e-04 | 891 | 129 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | spectrin binding | 1.36e-03 | 34 | 129 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 1.58e-03 | 337 | 129 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.80e-03 | 10 | 129 | 2 | GO:0140031 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FLI1 IKZF3 GATA3 IRF2 E2F2 BCL9 IFI16 ZEB2 CREB3L1 STAT4 FOSL1 PPP2R5B NFATC1 GLI3 CAPRIN2 PITX3 NKX2-5 ELK4 TAF6 TCF7L1 EBF4 ZNF292 CREB3L2 NOBOX | 4.26e-06 | 1390 | 128 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 2.98e-05 | 96 | 128 | 6 | GO:0006405 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.81e-07 | 109 | 129 | 8 | GO:0005796 | |
| GeneOntologyCellularComponent | chromatin | FLI1 FOXO6 INCENP GATA3 NPAS3 IRF2 E2F2 SRCAP KMT2E PIAS1 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 DBX1 PITX3 ANKRD17 NKX2-5 ELK4 TAF6 TCF7L1 CUX1 EBF4 CREB3L2 NOBOX | 1.03e-06 | 1480 | 129 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | main axon | 2.27e-04 | 89 | 129 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.42e-04 | 20 | 129 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | node of Ranvier | 2.42e-04 | 20 | 129 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | costamere | 3.24e-04 | 22 | 129 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | nuclear pore | 4.08e-04 | 101 | 129 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 5.58e-04 | 6 | 129 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | axon initial segment | 7.46e-04 | 29 | 129 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | microtubule minus-end | 7.78e-04 | 7 | 129 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.03e-03 | 8 | 129 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.52e-03 | 272 | 129 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | microtubule end | 1.65e-03 | 38 | 129 | 3 | GO:1990752 | |
| Domain | SEA | 3.22e-07 | 22 | 127 | 5 | PF01390 | |
| Domain | SEA | 4.10e-07 | 23 | 127 | 5 | PS50024 | |
| Domain | SEA_dom | 4.10e-07 | 23 | 127 | 5 | IPR000082 | |
| Domain | SEA | 1.94e-06 | 14 | 127 | 4 | SM00200 | |
| Domain | - | 1.32e-04 | 15 | 127 | 3 | 3.30.70.960 | |
| Domain | VDCC_T_a1 | 1.37e-04 | 3 | 127 | 2 | IPR005445 | |
| Domain | CTCK_1 | 2.33e-04 | 18 | 127 | 3 | PS01185 | |
| Domain | HIN_200 | 2.73e-04 | 4 | 127 | 2 | PS50834 | |
| Domain | HIN | 2.73e-04 | 4 | 127 | 2 | PF02760 | |
| Domain | HIN200/IF120x | 2.73e-04 | 4 | 127 | 2 | IPR004021 | |
| Domain | DAPIN | 4.30e-04 | 22 | 127 | 3 | PS50824 | |
| Domain | PYRIN | 4.30e-04 | 22 | 127 | 3 | SM01289 | |
| Domain | PYRIN | 4.30e-04 | 22 | 127 | 3 | PF02758 | |
| Domain | DAPIN | 4.30e-04 | 22 | 127 | 3 | IPR004020 | |
| Domain | CT | 4.30e-04 | 22 | 127 | 3 | SM00041 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 4.53e-04 | 5 | 127 | 2 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 4.53e-04 | 5 | 127 | 2 | IPR003937 | |
| Domain | KCNQ_channel | 4.53e-04 | 5 | 127 | 2 | PF03520 | |
| Domain | DEATH-like_dom | 5.77e-04 | 99 | 127 | 5 | IPR011029 | |
| Domain | Cys_knot_C | 6.33e-04 | 25 | 127 | 3 | IPR006207 | |
| Domain | CTCK_2 | 6.33e-04 | 25 | 127 | 3 | PS01225 | |
| Domain | WxxW_domain | 6.76e-04 | 6 | 127 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 6.76e-04 | 6 | 127 | 2 | PF13330 | |
| Domain | DEATH | 7.97e-04 | 27 | 127 | 3 | SM00005 | |
| Domain | DUF3585 | 9.42e-04 | 7 | 127 | 2 | IPR022735 | |
| Domain | DUF3585 | 9.42e-04 | 7 | 127 | 2 | PF12130 | |
| Domain | Death | 1.44e-03 | 33 | 127 | 3 | PF00531 | |
| Domain | bZIP_1 | 1.58e-03 | 34 | 127 | 3 | PF00170 | |
| Domain | ZU5 | 1.60e-03 | 9 | 127 | 2 | SM00218 | |
| Domain | VWFC_1 | 1.86e-03 | 36 | 127 | 3 | PS01208 | |
| Domain | Rap_GAP | 1.99e-03 | 10 | 127 | 2 | PF02145 | |
| Domain | ZU5 | 1.99e-03 | 10 | 127 | 2 | PS51145 | |
| Domain | VDCCAlpha1 | 1.99e-03 | 10 | 127 | 2 | IPR002077 | |
| Domain | TF_DNA-bd | 2.02e-03 | 37 | 127 | 3 | IPR008917 | |
| Domain | Znf_FYVE | 2.18e-03 | 38 | 127 | 3 | IPR000306 | |
| Domain | VWFC_2 | 2.18e-03 | 38 | 127 | 3 | PS50184 | |
| Domain | Death_domain | 2.18e-03 | 38 | 127 | 3 | IPR000488 | |
| Domain | VWC | 2.18e-03 | 38 | 127 | 3 | SM00214 | |
| Domain | DEATH_DOMAIN | 2.18e-03 | 38 | 127 | 3 | PS50017 | |
| Domain | Rap_GAP_dom | 2.42e-03 | 11 | 127 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.42e-03 | 11 | 127 | 2 | PS50085 | |
| Domain | ZF_FYVE | 2.52e-03 | 40 | 127 | 3 | PS50178 | |
| Domain | C8 | 2.90e-03 | 12 | 127 | 2 | PF08742 | |
| Domain | TIL | 2.90e-03 | 12 | 127 | 2 | PF01826 | |
| Domain | ZU5 | 2.90e-03 | 12 | 127 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.90e-03 | 12 | 127 | 2 | IPR000906 | |
| Domain | VWF_dom | 2.90e-03 | 42 | 127 | 3 | IPR001007 | |
| Domain | Znf_FYVE_PHD | 3.33e-03 | 147 | 127 | 5 | IPR011011 | |
| Domain | Unchr_dom_Cys-rich | 3.41e-03 | 13 | 127 | 2 | IPR014853 | |
| Domain | C8 | 3.41e-03 | 13 | 127 | 2 | SM00832 | |
| Domain | - | 3.73e-03 | 93 | 127 | 4 | 1.10.533.10 | |
| Domain | TIL_dom | 3.96e-03 | 14 | 127 | 2 | IPR002919 | |
| Domain | Glyco_hormone_CN | 4.55e-03 | 15 | 127 | 2 | IPR006208 | |
| Domain | Cys_knot | 4.55e-03 | 15 | 127 | 2 | PF00007 | |
| Domain | VWF_type-D | 5.17e-03 | 16 | 127 | 2 | IPR001846 | |
| Domain | VWFD | 5.17e-03 | 16 | 127 | 2 | PS51233 | |
| Domain | VWD | 5.17e-03 | 16 | 127 | 2 | SM00216 | |
| Domain | VWD | 5.17e-03 | 16 | 127 | 2 | PF00094 | |
| Domain | BRLZ | 5.32e-03 | 52 | 127 | 3 | SM00338 | |
| Domain | HOMEOBOX_1 | 5.55e-03 | 236 | 127 | 6 | PS00027 | |
| Domain | BZIP_BASIC | 5.61e-03 | 53 | 127 | 3 | PS00036 | |
| Domain | BZIP | 5.61e-03 | 53 | 127 | 3 | PS50217 | |
| Domain | HOX | 5.66e-03 | 237 | 127 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 5.90e-03 | 239 | 127 | 6 | PS50071 | |
| Domain | Homeobox_dom | 5.90e-03 | 239 | 127 | 6 | IPR001356 | |
| Domain | bZIP | 5.92e-03 | 54 | 127 | 3 | IPR004827 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.55e-06 | 16 | 89 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.32e-06 | 17 | 89 | 4 | M27412 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.13e-06 | 43 | 89 | 5 | MM14609 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.18e-06 | 21 | 89 | 4 | MM15706 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.11e-05 | 47 | 89 | 5 | MM14939 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.20e-05 | 23 | 89 | 4 | M556 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.52e-05 | 50 | 89 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.67e-05 | 51 | 89 | 5 | MM15151 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.67e-05 | 86 | 89 | 6 | MM15413 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.00e-05 | 26 | 89 | 4 | M27483 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.43e-05 | 55 | 89 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.49e-05 | 65 | 89 | 5 | MM15147 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.83e-05 | 68 | 89 | 5 | M27303 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.49e-05 | 36 | 89 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 7.49e-05 | 36 | 89 | 4 | M27245 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.03e-04 | 39 | 89 | 4 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.14e-04 | 40 | 89 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.26e-04 | 41 | 89 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.38e-04 | 42 | 89 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.52e-04 | 43 | 89 | 4 | M26975 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.87e-04 | 84 | 89 | 5 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.87e-04 | 84 | 89 | 5 | M725 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.98e-04 | 46 | 89 | 4 | M27397 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.53e-04 | 49 | 89 | 4 | MM14837 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.55e-04 | 140 | 89 | 6 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.86e-04 | 143 | 89 | 6 | M27275 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.43e-04 | 53 | 89 | 4 | M27212 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 4.47e-04 | 24 | 89 | 3 | MM15658 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.47e-04 | 24 | 89 | 3 | M47509 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.86e-04 | 58 | 89 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.86e-04 | 58 | 89 | 4 | MM14736 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.06e-04 | 25 | 89 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.06e-04 | 25 | 89 | 3 | M47511 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.53e-04 | 60 | 89 | 4 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.25e-04 | 109 | 89 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.26e-04 | 62 | 89 | 4 | M546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.79e-04 | 111 | 89 | 5 | M27416 | |
| Pathway | REACTOME_SUMOYLATION | 6.94e-04 | 169 | 89 | 6 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 7.66e-04 | 114 | 89 | 5 | MM15361 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 8.73e-04 | 30 | 89 | 3 | M47752 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.62e-04 | 31 | 89 | 3 | M877 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.02e-03 | 250 | 89 | 7 | M27554 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.04e-03 | 71 | 89 | 4 | M27394 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.06e-03 | 32 | 89 | 3 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.16e-03 | 33 | 89 | 3 | M27016 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.16e-03 | 73 | 89 | 4 | MM14948 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.22e-03 | 74 | 89 | 4 | M48006 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.26e-03 | 34 | 89 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.38e-03 | 35 | 89 | 3 | M27320 | |
| Pathway | REACTOME_CREB3_FACTORS_ACTIVATE_GENES | 1.38e-03 | 9 | 89 | 2 | M27773 | |
| Pathway | WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS | 1.38e-03 | 9 | 89 | 2 | M48307 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.41e-03 | 77 | 89 | 4 | M27226 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.62e-03 | 37 | 89 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.62e-03 | 37 | 89 | 3 | M27038 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.63e-03 | 80 | 89 | 4 | M223 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.72e-03 | 10 | 89 | 2 | MM14644 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.78e-03 | 82 | 89 | 4 | MM15394 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 2.09e-03 | 11 | 89 | 2 | M655 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 2.18e-03 | 41 | 89 | 3 | M29574 | |
| Pathway | WNT_SIGNALING | 2.41e-03 | 89 | 89 | 4 | M5493 | |
| Pathway | KEGG_PROSTATE_CANCER | 2.41e-03 | 89 | 89 | 4 | M13191 | |
| Pathway | WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING | 2.50e-03 | 43 | 89 | 3 | M45516 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.50e-03 | 43 | 89 | 3 | M1429 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 2.66e-03 | 151 | 89 | 5 | M39801 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.67e-03 | 44 | 89 | 3 | M109 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.72e-03 | 92 | 89 | 4 | MM14951 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FLI1 IKZF3 GATA3 NPAS3 IRF2 E2F2 ZEB2 CREB3L1 STAT4 FOSL1 NFATC1 DBX1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 EBF4 CREB3L2 NOBOX | 2.27e-10 | 908 | 131 | 20 | 19274049 |
| Pubmed | ANK3 NUP98 RAP1GAP2 NUP214 MUC12 SIK3 PIAS1 ZC3H7A POM121 RASAL3 NAV1 PAK2 ANKRD17 HELZ CUX1 | 5.30e-10 | 486 | 131 | 15 | 20936779 | |
| Pubmed | IRF2BP2 FLI1 IKZF3 SCAF8 SEC24A NUP98 GATA3 NUP214 MAP7 BCL9 GTPBP1 SRCAP PIAS1 ZEB2 STAT4 GLI3 EIF4G1 ANKRD17 NKX2-5 HELZ ELK4 TAF6 NXF1 CUX1 | 7.24e-10 | 1429 | 131 | 24 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 IRF2BP2 SYNRG ACACA MAP4 SCAF8 CAMSAP3 NUP98 RFFL NUP214 IQCN BCL9 IFI16 EIF4G1 ANKRD17 HELZ MICAL3 TAF6 | 8.37e-10 | 774 | 131 | 18 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG ACACA MAP4 SEC24A SIPA1L3 CAMSAP3 CCDC18 SIK3 MAP7 NEK9 TRAK1 PTK2B PIK3C2A EIF4G1 NAV1 ANKRD17 HELZ PRRC1 | 4.42e-09 | 861 | 131 | 18 | 36931259 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.78e-09 | 18 | 131 | 5 | 18834073 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SPATA31E1 ANK3 NUP98 NUP214 BCL9 KMT2E PIAS1 NEK9 POM121 RASAL3 NKX2-5 BSN PRRC1 | 1.02e-08 | 430 | 131 | 13 | 35044719 |
| Pubmed | THOC1 DNAJB12 IRF2BP2 TDRKH ANK3 MAP4 SCAF8 NUP214 GTPBP1 EIF4G1 MICAL3 NXF1 | 4.57e-08 | 403 | 131 | 12 | 35253629 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | FLI1 GATA3 IRF2 E2F2 CREB3L1 FOSL1 NFATC1 GLI3 PITX3 NKX2-5 ELK4 TCF7L1 CUX1 | 1.57e-07 | 544 | 131 | 13 | 28473536 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | DNAJB12 IRF2BP2 SCAF8 SEC24A NUP98 NUP214 BCL9 POM121 PIK3C2A ANKRD17 HELZ NXF1 | 1.78e-07 | 457 | 131 | 12 | 32344865 |
| Pubmed | In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of Tap. | 2.08e-07 | 4 | 131 | 3 | 11551912 | |
| Pubmed | GATA3 E2F2 SRCAP PIAS1 STAT4 PER3 NFATC1 GLI3 HMGXB3 TAF6 TCF7L1 CUX1 ZNF292 CREB3L2 NOBOX | 4.29e-07 | 808 | 131 | 15 | 20412781 | |
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 5.19e-07 | 5 | 131 | 3 | 19109891 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.24e-07 | 184 | 131 | 8 | 32908313 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | THOC1 SYNRG HAUS6 ACACA MAP4 GTPBP1 ZC3H7A PIK3C2A EIF4G1 PAK2 ANKRD17 HELZ NXF1 ZNF292 | 6.59e-07 | 724 | 131 | 14 | 36232890 |
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 19110483 | ||
| Pubmed | 2.41e-06 | 101 | 131 | 6 | 26949739 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG IKZF3 E2F2 MAP7 SRCAP PIAS1 ZC3H7A NFATC1 NAV1 HELZ BSN NXF1 | 2.49e-06 | 588 | 131 | 12 | 38580884 |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 2.88e-06 | 8 | 131 | 3 | 31375530 | |
| Pubmed | HAUS6 MAP4 CAMSAP3 NUP98 MAP7 IFI16 MTM1 MYPN EIF4G1 PAK2 TAF6 | 3.46e-06 | 503 | 131 | 11 | 16964243 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 3.83e-06 | 321 | 131 | 9 | 32098917 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PHLDB3 SYNRG RTL6 ACACA SIPA1L3 RAP1GAP2 NUP214 BCL9 SRCAP TRAK1 NFATC1 EIF4G1 NAV1 CACNA1H HMGXB3 MICAL3 | 4.38e-06 | 1105 | 131 | 16 | 35748872 |
| Pubmed | 4.48e-06 | 418 | 131 | 10 | 34709266 | ||
| Pubmed | 5.62e-06 | 67 | 131 | 5 | 29254152 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.76e-06 | 180 | 131 | 7 | 35198878 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 6.13e-06 | 256 | 131 | 8 | 33397691 | |
| Pubmed | A role for primary cilia in aortic valve development and disease. | 6.15e-06 | 10 | 131 | 3 | 28556366 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 7.54e-06 | 123 | 131 | 6 | 26912792 | |
| Pubmed | HAUS6 ACACA LGALS14 IRF2 NUP214 MUC12 PIAS1 ZC3H7A DBX1 GLI3 EIF4G1 PAK2 ANKRD17 HELZ TAF6 NXF1 ZNF292 | 1.08e-05 | 1327 | 131 | 17 | 32694731 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.15e-05 | 37 | 131 | 4 | 25798587 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 SYNRG HAUS6 ACACA ANK2 MAP4 NUP98 NUP214 SRCAP NEK9 PAK2 ANKRD17 HELZ TAF6 | 1.23e-05 | 934 | 131 | 14 | 33916271 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 BEST1 ACACA ANK3 MAP4 SCAF8 SIPA1L3 CAMSAP3 IQCN NEK9 NFATC1 NAV1 ANKRD17 CACNA1H MICAL3 ELK4 CUX1 CREB3L2 | 1.27e-05 | 1489 | 131 | 18 | 28611215 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 1.27e-05 | 283 | 131 | 8 | 18854154 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.28e-05 | 38 | 131 | 4 | 12791264 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.41e-05 | 2 | 131 | 2 | 12808460 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 25071191 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 36786913 | ||
| Pubmed | Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts. | 1.41e-05 | 2 | 131 | 2 | 24614117 | |
| Pubmed | The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity. | 1.41e-05 | 2 | 131 | 2 | 21041443 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 36805539 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 30044774 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 10025409 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 31570526 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 19684152 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 1.41e-05 | 2 | 131 | 2 | 25383926 | |
| Pubmed | Activation of OASIS family, ER stress transducers, is dependent on its stabilization. | 1.41e-05 | 2 | 131 | 2 | 22705851 | |
| Pubmed | Study of mucin turnover in the small intestine by in vivo labeling. | 1.41e-05 | 2 | 131 | 2 | 29636525 | |
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 1.41e-05 | 2 | 131 | 2 | 20873538 | |
| Pubmed | 1.52e-05 | 209 | 131 | 7 | 36779422 | ||
| Pubmed | ANK2 ANK3 SIPA1L3 CAMSAP3 SIK3 BCL9 NEK9 ZEB2 EIF4G1 NAV1 PAK2 ANKRD17 BSN CUX1 | 1.73e-05 | 963 | 131 | 14 | 28671696 | |
| Pubmed | 1.84e-05 | 14 | 131 | 3 | 32151560 | ||
| Pubmed | 1.84e-05 | 14 | 131 | 3 | 11073998 | ||
| Pubmed | 2.30e-05 | 15 | 131 | 3 | 14697343 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.39e-05 | 90 | 131 | 5 | 35654790 | |
| Pubmed | 2.82e-05 | 16 | 131 | 3 | 25924204 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FLI1 GATA3 E2F2 ZEB2 CREB3L1 CSDC2 FOSL1 GLI3 PITX3 NKX2-5 HMGXB3 EBF4 ZNF292 | 2.87e-05 | 877 | 131 | 13 | 20211142 |
| Pubmed | THOC1 DNAJB12 IRF2BP2 INCENP MAP4 NUP98 IFI16 PIAS1 FOSL1 TRIM11 EIF4G1 PAK2 TAF6 NXF1 | 3.04e-05 | 1014 | 131 | 14 | 32416067 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS6 INCENP SIPA1L3 NUP98 C11orf24 NUP214 NEK9 PER3 MICALL2 MYPN EIF4G1 MICAL3 PRRC1 NXF1 CREB3L2 | 3.16e-05 | 1155 | 131 | 15 | 20360068 |
| Pubmed | 3.42e-05 | 17 | 131 | 3 | 10668806 | ||
| Pubmed | TDRKH HAUS6 ACACA ANK3 INCENP SEC24A SCYL3 NUP98 MUC16 GLI3 PRRC1 CUX1 | 3.99e-05 | 777 | 131 | 12 | 35844135 | |
| Pubmed | 4.09e-05 | 18 | 131 | 3 | 24735878 | ||
| Pubmed | 4.09e-05 | 18 | 131 | 3 | 37321992 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 25216923 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 4.21e-05 | 3 | 131 | 2 | 23488970 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 4.21e-05 | 3 | 131 | 2 | 30802453 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27114368 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 4.21e-05 | 3 | 131 | 2 | 11230107 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15637551 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 35507432 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 4.21e-05 | 3 | 131 | 2 | 28972185 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15611082 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 26770020 | ||
| Pubmed | Inhibition of cellular functions of HIV-1 Nef by artificial SH3 domains. | 4.21e-05 | 3 | 131 | 2 | 11448168 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 10512748 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 9847314 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 21867929 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 11897840 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 24005989 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 8943370 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 14762142 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 19718741 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 4.21e-05 | 3 | 131 | 2 | 18591418 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27230679 | ||
| Pubmed | Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. | 4.21e-05 | 3 | 131 | 2 | 16393972 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 28846697 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 18786918 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 11927664 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15234964 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 20065027 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 4.21e-05 | 3 | 131 | 2 | 33410423 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 26969140 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 18772129 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 37353480 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12589057 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 11352827 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 4.21e-05 | 3 | 131 | 2 | 21327100 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 17721195 | ||
| Interaction | NUP50 interactions | ACACA NUP98 NUP214 IFI16 POM121 EIF4G1 PAK2 HELZ NXF1 CUX1 ZNF292 | 1.34e-05 | 341 | 130 | 11 | int:NUP50 |
| Interaction | NUP35 interactions | IRF2BP2 SCAF8 SEC24A NUP98 NUP214 BCL9 IFI16 POM121 PIK3C2A ANKRD17 HELZ NXF1 | 1.98e-05 | 424 | 130 | 12 | int:NUP35 |
| Interaction | HDAC1 interactions | HAUS6 IKZF3 ACACA CAMSAP3 NUP98 GATA3 NUP214 KMT2E NEK9 ZEB2 TRAK1 FOSL1 NFATC1 GLI3 NAV1 ANKRD17 NKX2-5 TAF6 NXF1 CUX1 | 2.80e-05 | 1108 | 130 | 20 | int:HDAC1 |
| Interaction | SYNE3 interactions | DNAJB12 SYNRG SEC24A SIPA1L3 CAMSAP3 CCDC18 NUP98 NUP214 PIK3C2A GLI3 NAV1 HELZ | 3.11e-05 | 444 | 130 | 12 | int:SYNE3 |
| Interaction | TLE3 interactions | IRF2BP2 ANK3 SCAF8 SEC24A GATA3 BCL9 PIAS1 POM121 NKX2-5 HELZ CUX1 | 3.30e-05 | 376 | 130 | 11 | int:TLE3 |
| Interaction | E2F4 interactions | THOC1 DNAJB12 IRF2BP2 TDRKH ANK3 MAP4 SCAF8 E2F2 NUP214 GTPBP1 EIF4G1 MICAL3 NXF1 | 4.77e-05 | 540 | 130 | 13 | int:E2F4 |
| Interaction | AGRN interactions | 5.99e-05 | 267 | 130 | 9 | int:AGRN | |
| Interaction | TOP3B interactions | THOC1 PHLDB3 SYNRG TDRKH RTL6 ACACA SEC24A SIPA1L3 RAP1GAP2 NUP214 BCL9 GTPBP1 SRCAP TRAK1 ZC3H7A NFATC1 EIF4G1 NAV1 ANKRD17 HELZ CACNA1H HMGXB3 MICAL3 | 6.20e-05 | 1470 | 130 | 23 | int:TOP3B |
| Interaction | NUP62 interactions | 7.11e-05 | 273 | 130 | 9 | int:NUP62 | |
| Interaction | GABARAPL1 interactions | 7.22e-05 | 157 | 130 | 7 | int:GABARAPL1 | |
| Cytoband | 7q22.1 | 3.20e-04 | 113 | 131 | 4 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 4.31e-04 | 219 | 131 | 5 | chr7q22 | |
| GeneFamily | CD molecules|Mucins | 7.02e-10 | 21 | 91 | 6 | 648 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.48e-04 | 5 | 91 | 2 | 995 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.62e-04 | 25 | 91 | 3 | 994 | |
| GeneFamily | Nucleoporins | 5.50e-04 | 32 | 91 | 3 | 1051 | |
| GeneFamily | Basic leucine zipper proteins | 1.92e-03 | 49 | 91 | 3 | 506 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLI1 SYNRG HAUS6 IKZF3 SCAF8 SH2D3C NUP98 GATA3 RCSD1 SIK3 KMT2E IFI16 NEK9 ZEB2 USP20 STAT4 PYHIN1 PTK2B RASAL3 PAK2 HELZ ELK4 TNFRSF1B FGD3 ZNF292 | 7.39e-08 | 1492 | 130 | 25 | M40023 |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 5.39e-06 | 136 | 130 | 7 | MM407 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SCAF8 SEC24A NUP98 E2F2 TRAK1 ANKRD17 HELZ MICAL3 CUX1 ZNF292 CREB3L2 | 2.17e-05 | 466 | 130 | 11 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | IKZF3 ANK2 ANK3 GATA3 NPAS3 RAP1GAP2 NPDC1 SIK3 KMT2E VCAN CAPRIN2 NAV1 KCNQ3 CACNA1I MICAL3 BSN MUC2 | 3.44e-05 | 1106 | 130 | 17 | M39071 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 3.70e-05 | 183 | 130 | 7 | M8189 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | SYNRG IKZF3 SH2D3C GATA3 KMT2E IFI16 USP20 STAT4 PTK2B RASAL3 HELZ ELK4 SKAP2 NXF1 ZNF292 | 4.76e-05 | 911 | 130 | 15 | M40038 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 5.90e-05 | 197 | 130 | 7 | M5378 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP | 6.15e-05 | 136 | 130 | 6 | M1894 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 6.29e-05 | 199 | 130 | 7 | M3417 | |
| Coexpression | BUSSLINGER_DUODENAL_GOBLET_CELLS | 6.37e-05 | 16 | 130 | 3 | M40031 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.06e-06 | 89 | 127 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | IRF2BP2 ANK3 MAP4 GATA3 NPAS3 NUP214 IFI16 ZEB2 CLCA1 PIK3C2A VCAN EIF4G1 CUX1 | 1.31e-06 | 416 | 127 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | IRF2BP2 ANK2 ANK3 MAP4 SIPA1L3 GATA3 NPAS3 NUP214 BCL9 IFI16 ZEB2 CCN4 CLCA1 PIK3C2A GLI3 VCAN EIF4G1 CUX1 | 1.83e-06 | 818 | 127 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 CSDC2 TRAK1 SSC5D CLIP3 CACNA1H ELK4 TCF7L1 NXF1 EBF4 | 2.32e-06 | 747 | 127 | 17 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | MUC16 BCL9 ZEB2 CREB3L1 CSDC2 CLIP3 CLCA1 GLI3 VCAN TCF7L1 CUX1 | 4.44e-06 | 327 | 127 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 CSDC2 TRAK1 SSC5D CLIP3 CACNA1H ELK4 TCF7L1 EBF4 | 6.60e-06 | 722 | 127 | 16 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG TDRKH RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 TRAK1 SSC5D GLI3 CACNA1H ELK4 TCF7L1 EBF4 | 7.84e-06 | 732 | 127 | 16 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG TDRKH RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 CSDC2 TRAK1 CLIP3 CACNA1H ELK4 TCF7L1 EBF4 | 9.44e-06 | 743 | 127 | 16 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CCDC18 MUC16 BCL9 ZEB2 CREB3L1 CSDC2 IGSF10 CCN4 CLIP3 CLCA1 GLI3 VCAN NAV1 CACNA1H TCF7L1 CUX1 | 1.64e-05 | 777 | 127 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.76e-05 | 246 | 127 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | MUC16 BCL9 CREB3L1 CSDC2 IGSF10 CLIP3 CLCA1 GLI3 VCAN TCF7L1 | 1.81e-05 | 311 | 127 | 10 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | IRF2BP2 ANK3 NUP214 BCL9 ZEB2 CCN4 PIK3C2A GLI3 VCAN EIF4G1 CUX1 | 2.05e-05 | 385 | 127 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | TDRKH HAUS6 ANK2 INCENP CAMSAP3 CCDC18 NPAS3 MAP7 BCL9 KMT2E TRAK1 ZC3H7A CLIP3 RASAL3 GLI3 CUX1 EBF4 SEZ6 | 2.26e-05 | 983 | 127 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 TRAK1 SSC5D CLIP3 CACNA1H ELK4 TCF7L1 EBF4 | 3.15e-05 | 730 | 127 | 15 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 3.79e-05 | 209 | 127 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 KMT2E USP20 TRAK1 SSC5D CACNA1H ELK4 TCF7L1 EBF4 | 4.11e-05 | 659 | 127 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 USP20 CSDC2 TRAK1 SSC5D CACNA1H ELK4 TCF7L1 EBF4 | 6.52e-05 | 688 | 127 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CCDC18 MUC16 BCL9 ZEB2 CREB3L1 CSDC2 IGSF10 CCN4 PTK2B CLIP3 CLCA1 GLI3 VCAN CACNA1H TCF7L1 | 8.03e-05 | 793 | 127 | 15 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | RTL6 ACACA ANK3 SIPA1L3 GATA3 NPAS3 NUP214 BCL9 IFI16 CLIP3 CLCA1 PIK3C2A GLI3 VCAN CUX1 | 9.62e-05 | 806 | 127 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.76e-05 | 123 | 127 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.07e-04 | 125 | 127 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.11e-04 | 312 | 127 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 1.21e-04 | 390 | 127 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | IRF2BP2 NUP214 ZEB2 PIK3C2A GLI3 VCAN EIF4G1 TCF7L1 PRRC1 CUX1 | 1.40e-04 | 397 | 127 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 USP20 CSDC2 SSC5D CACNA1H ELK4 TCF7L1 EBF4 | 1.61e-04 | 658 | 127 | 13 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.71e-04 | 407 | 127 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | THOC1 TDRKH HAUS6 IKZF3 ANK3 RCSD1 NUP214 BCL9 SRCAP PIK3C2A VCAN CUX1 MYBPC1 ZNF292 | 2.38e-04 | 779 | 127 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.52e-04 | 207 | 127 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.55e-04 | 349 | 127 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 2.58e-04 | 147 | 127 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.67e-04 | 209 | 127 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 2.78e-04 | 149 | 127 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.98e-04 | 151 | 127 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.27e-04 | 361 | 127 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.80e-04 | 158 | 127 | 6 | gudmap_developingGonad_e12.5_testes_k5_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 4.15e-04 | 373 | 127 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | IRF2BP2 FLI1 HAUS6 NPAS3 IFI16 PIAS1 ZEB2 ZC3H7A CLCA1 GLI3 VCAN PRRC1 CUX1 ZNF292 | 4.30e-04 | 826 | 127 | 14 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.62e-04 | 107 | 127 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 4.94e-04 | 166 | 127 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 USP20 CSDC2 TRAK1 CACNA1H ELK4 TCF7L1 EBF4 | 5.44e-04 | 747 | 127 | 13 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 5.50e-04 | 27 | 127 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.63e-04 | 310 | 127 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | IRF2BP2 MUC16 BCL9 CREB3L1 CSDC2 IGSF10 PTK2B CLIP3 CLCA1 POM121 GLI3 VCAN TCF7L1 MYBPC1 | 5.64e-04 | 849 | 127 | 14 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.11e-04 | 240 | 127 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 7.13e-04 | 178 | 127 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 7.54e-04 | 30 | 127 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | CAMSAP3 CCDC18 GATA3 MAP7 BCL9 PTK2B SSC5D CLIP3 RASAL3 GLI3 | 7.59e-04 | 492 | 127 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 8.39e-04 | 122 | 127 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | THOC1 FLI1 CAMSAP3 CCDC18 GATA3 C11orf24 MAP7 BCL9 PTK2B SSC5D CLIP3 RASAL3 GLI3 NAV1 ZNF292 | 8.44e-04 | 989 | 127 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.48e-04 | 184 | 127 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K4 | 8.70e-04 | 123 | 127 | 5 | facebase_RNAseq_e10.5_MaxArch_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MAP4 DAG1 SRCAP KMT2E ZEB2 CREB3L1 CSDC2 CCN4 CLIP3 EIF4G1 NAV1 BOLL MYBPC1 | 9.11e-04 | 790 | 127 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_500 | 9.13e-04 | 32 | 127 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.35e-04 | 125 | 127 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.67e-04 | 337 | 127 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.99e-04 | 261 | 127 | 7 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 1.00e-03 | 33 | 127 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.03e-03 | 191 | 127 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.09e-03 | 265 | 127 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 1.12e-03 | 76 | 127 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 1.12e-03 | 76 | 127 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | IRF2BP2 NPAS3 NUP214 IFI16 ZEB2 CLCA1 PIK3C2A GLI3 VCAN EIF4G1 TCF7L1 PRRC1 CUX1 | 1.16e-03 | 811 | 127 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 1.24e-03 | 78 | 127 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 1.24e-03 | 78 | 127 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | SYNRG RTL6 ANK2 NPAS3 NPDC1 E2F2 USP20 TRAK1 CACNA1H ELK4 TCF7L1 EBF4 | 1.31e-03 | 721 | 127 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.32e-03 | 354 | 127 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | C11orf24 SIK3 KMT2E NEK9 CREB3L1 CSDC2 IGSF10 CCN4 CLIP3 RASAL3 NFATC1 VCAN CACNA1H EBF4 MYBPC1 CREB3L2 | 1.37e-03 | 1148 | 127 | 16 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FLI1 ACACA MUC16 BCL9 ZEB2 CREB3L1 PTK2B CLIP3 CLCA1 GLI3 VCAN MYBPC1 CREB3L2 | 1.38e-03 | 827 | 127 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_200 | 1.40e-03 | 37 | 127 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 1.40e-03 | 37 | 127 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FLI1 IKZF3 RAP1GAP2 RCSD1 IFI16 ZEB2 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 1.86e-11 | 200 | 130 | 11 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FLI1 IKZF3 RAP1GAP2 RCSD1 IFI16 ZEB2 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 1.86e-11 | 200 | 130 | 11 | d2422aaf807010194994db97142b9fd2e807312d |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FLI1 IKZF3 RAP1GAP2 RCSD1 IFI16 ZEB2 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 1.86e-11 | 200 | 130 | 11 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FLI1 IKZF3 RCSD1 IFI16 ZEB2 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 3.48e-10 | 197 | 130 | 10 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FLI1 IKZF3 SH2D3C GATA3 RCSD1 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 3.84e-10 | 199 | 130 | 10 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FLI1 IKZF3 SH2D3C GATA3 RCSD1 STAT4 PYHIN1 RASAL3 TNFRSF1B FGD3 | 4.03e-10 | 200 | 130 | 10 | d8459e45a8396a9ee063666a1928c649162c5727 |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-09 | 170 | 130 | 9 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 5.01e-09 | 190 | 130 | 9 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | control-Lymphoid-Treg|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.49e-09 | 192 | 130 | 9 | 9067e90b7c2d734100d6e5026d753113bf9428a3 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.01e-09 | 194 | 130 | 9 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-09 | 195 | 130 | 9 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-09 | 197 | 130 | 9 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.50e-09 | 199 | 130 | 9 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-09 | 200 | 130 | 9 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-09 | 200 | 130 | 9 | 68589705dbc84482b6c0a1a27dd552492c4e8c3d | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-09 | 200 | 130 | 9 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-09 | 200 | 130 | 9 | dbbc7e16929e744b48017da068479a6046e99cf6 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 130 | 8 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 130 | 8 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 8.08e-08 | 187 | 130 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-08 | 189 | 130 | 8 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-08 | 189 | 130 | 8 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-08 | 189 | 130 | 8 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 9.13e-08 | 190 | 130 | 8 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.51e-08 | 191 | 130 | 8 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 194 | 130 | 8 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | PSB-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-07 | 195 | 130 | 8 | e585d264dec3010134bb6aecbed85b2256f23c79 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-07 | 197 | 130 | 8 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.25e-07 | 198 | 130 | 8 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 598937913fe1f12d741fa49e23ae195a7be5cbe3 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 713fab2e946b300d21215aff1553785e8857ce65 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 7d69785717073491b5fb81bf24db0175f86cd0b0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 54b64f01e7a73a88bd92b6d4e73cccde60396b2d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | 01ae5ce8e0a1d3bd1cc975b16f53c13bbc13189d | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-07 | 199 | 130 | 8 | ffd5b4d58d81b76e01d87016209f16879d81c592 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-07 | 199 | 130 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | 13d8c5d65d7f900979319433e7044efa6d06de20 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | ee5bb02fad48a77e3cc8c77cc086a1638764d580 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-07 | 200 | 130 | 8 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-07 | 149 | 130 | 7 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-07 | 165 | 130 | 7 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 6.67e-07 | 169 | 130 | 7 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-07 | 176 | 130 | 7 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-07 | 176 | 130 | 7 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 181 | 130 | 7 | 8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.22e-06 | 185 | 130 | 7 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 185 | 130 | 7 | 45890fa81c65a48f4fdec164a4c8d0e2831243c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 185 | 130 | 7 | 585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 1.22e-06 | 185 | 130 | 7 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 186 | 130 | 7 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 186 | 130 | 7 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 186 | 130 | 7 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 187 | 130 | 7 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.36e-06 | 188 | 130 | 7 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-06 | 189 | 130 | 7 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 130 | 7 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 191 | 130 | 7 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 191 | 130 | 7 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 191 | 130 | 7 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.51e-06 | 191 | 130 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 191 | 130 | 7 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 191 | 130 | 7 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 191 | 130 | 7 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | NS-control-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-06 | 192 | 130 | 7 | ef252dd9df161f665f53c047c0514381f80d6683 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 193 | 130 | 7 | 91a1c9b8390cbd881db8c49d8f34feca0d1067d6 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 193 | 130 | 7 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 193 | 130 | 7 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.62e-06 | 193 | 130 | 7 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 193 | 130 | 7 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 193 | 130 | 7 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 130 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 194 | 130 | 7 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 194 | 130 | 7 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 194 | 130 | 7 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 130 | 7 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-06 | 195 | 130 | 7 | e1b7ef4ba2ab14d3c839b6305d91efcfd0826220 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-06 | 195 | 130 | 7 | 4a60b51f92830882872f2fe1a911db2970faf071 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.80e-06 | 196 | 130 | 7 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 196 | 130 | 7 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 196 | 130 | 7 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.80e-06 | 196 | 130 | 7 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 196 | 130 | 7 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | control-Lymphoid|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.80e-06 | 196 | 130 | 7 | 8ed172bb3a95f09722476f0880ae246561777d98 | |
| ToppCell | NS-control-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-06 | 197 | 130 | 7 | bd3f2d68eb108fe31e217c9124183920e7c82582 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.86e-06 | 197 | 130 | 7 | af16598a87c21c626e97e277e2deff4882e3eda2 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.86e-06 | 197 | 130 | 7 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-06 | 198 | 130 | 7 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 199 | 130 | 7 | 09e0b45529fa9d5fc86da1747b3fb3a238a09aa6 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 199 | 130 | 7 | 868ff080f72b6274a84e3ae0ddee4a32ed96472a | |
| ToppCell | VE-CD4-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.99e-06 | 199 | 130 | 7 | 6b00a393ad06ae91bf135a54a53ad4de68956193 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 199 | 130 | 7 | 3f4907fa6d81c5691c19e6798145e9f9eccdfd20 | |
| Drug | rufinamide | 5.75e-07 | 29 | 129 | 5 | CID000129228 | |
| Drug | bismuth aluminate | 3.51e-06 | 6 | 129 | 3 | CID000166681 | |
| Drug | Succimer | THOC1 FLI1 HAUS6 ANK3 ACY3 SCYL3 E2F2 SIK3 KMT2E IFI16 ZEB2 FOSL1 MICALL2 GLI3 NAV1 HELZ TNFRSF1B PRRC1 CUX1 FGD3 ZNF292 | 8.53e-06 | 1264 | 129 | 21 | ctd:D004113 |
| Drug | eslicarbazepine acetate | 9.75e-06 | 8 | 129 | 3 | CID000179344 | |
| Drug | Magnetite Nanoparticles | THOC1 FLI1 HAUS6 ANK3 ACY3 SCYL3 E2F2 SIK3 KMT2E IFI16 ZEB2 FOSL1 MICALL2 GLI3 NAV1 HELZ TNFRSF1B PRRC1 CUX1 FGD3 ZNF292 | 1.46e-05 | 1310 | 129 | 21 | ctd:D058185 |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.52e-05 | 194 | 129 | 8 | 4422_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; HL60; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 2570_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 3315_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 1222_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 5533_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 6031_DN | |
| Drug | spiromesifen | 3.19e-05 | 2 | 129 | 2 | CID009907412 | |
| Drug | isopentenyladenine | 7.67e-05 | 40 | 129 | 4 | CID000092180 | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; HL60; HT_HG-U133A | 8.76e-05 | 184 | 129 | 7 | 2711_UP | |
| Drug | ezogabine | 9.52e-05 | 3 | 129 | 2 | ctd:C101866 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 9.52e-05 | 3 | 129 | 2 | CID010679219 | |
| Drug | SureCN2398996 | 9.52e-05 | 3 | 129 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 9.52e-05 | 3 | 129 | 2 | CID000092154 | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.00e-04 | 188 | 129 | 7 | 5116_DN | |
| Drug | linopirdine | 1.02e-04 | 43 | 129 | 4 | CID000003932 | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 1.11e-04 | 191 | 129 | 7 | 7525_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A | 1.11e-04 | 191 | 129 | 7 | 1417_UP | |
| Drug | Supramid | 1.14e-04 | 17 | 129 | 3 | CID000005326 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.18e-04 | 193 | 129 | 7 | 4161_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 2430_DN | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 6897_UP | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 2863_UP | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 5070_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 1688_DN | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 3834_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 7468_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 1.26e-04 | 195 | 129 | 7 | 1886_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 3233_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 3277_UP | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 5073_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 7335_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 3211_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; PC3; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 7150_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 3277_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 2732_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 3128_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 2460_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 6053_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 4789_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 2345_UP | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 3839_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; PC3; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 2050_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 1699_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 5789_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 7343_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 5804_DN | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 7287_UP | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 6075_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 3840_UP | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 4481_UP | |
| Disease | eosinophil count | FLI1 IKZF3 SIPA1L3 LGALS14 CCDC18 GATA3 RAP1GAP2 E2F2 SIK3 PIAS1 STAT4 FOSL1 PTK2B RASAL3 PAK2 CACNA1H TNFRSF1B MUC2 SKAP2 CUX1 ZNF292 | 1.72e-06 | 1488 | 128 | 21 | EFO_0004842 |
| Disease | eosinophil percentage of leukocytes | FLI1 IKZF3 LGALS14 CCDC18 GATA3 SIK3 PIAS1 FOSL1 PTK2B TNFRSF1B MUC2 CUX1 ZNF292 | 2.28e-05 | 746 | 128 | 13 | EFO_0007991 |
| Disease | Fibromyxosarcoma | 5.59e-05 | 3 | 128 | 2 | C3714524 | |
| Disease | Vitelliform Macular Dystrophy | 1.11e-04 | 4 | 128 | 2 | C0339510 | |
| Disease | Juvenile-Onset Vitelliform Macular Dystrophy | 1.11e-04 | 4 | 128 | 2 | C2745945 | |
| Disease | Adult-Onset Vitelliform Macular Dystrophy | 1.11e-04 | 4 | 128 | 2 | C1842914 | |
| Disease | diastolic blood pressure, systolic blood pressure | ANK2 ANK3 BCL9 KMT2E PIAS1 NAV1 NKX2-5 SKAP2 TCF7L1 CUX1 CREB3L2 | 1.68e-04 | 670 | 128 | 11 | EFO_0006335, EFO_0006336 |
| Disease | vitelliform macular dystrophy (is_implicated_in) | 1.85e-04 | 5 | 128 | 2 | DOID:0050661 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | SH2D3C GATA3 RAP1GAP2 IFI16 ZC3H7A NFATC1 HELZ SKAP2 TCF7L1 ZNF292 | 3.39e-04 | 610 | 128 | 10 | EFO_0007990 |
| Disease | Hodgkins lymphoma | 4.55e-04 | 82 | 128 | 4 | EFO_0000183 | |
| Disease | hippocampus molecular layer volume | 4.71e-04 | 35 | 128 | 3 | EFO_0009397 | |
| Disease | lymphocyte count | FLI1 SYNRG IKZF3 ACACA GATA3 RAP1GAP2 NPDC1 E2F2 RASAL3 NFATC1 PAK2 NKX2-5 HELZ MICAL3 ELK4 SKAP2 | 6.13e-04 | 1464 | 128 | 16 | EFO_0004587 |
| Disease | basophil count, eosinophil count | 6.60e-04 | 241 | 128 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | lymphocyte percentage of leukocytes | FLI1 IKZF3 GATA3 RAP1GAP2 IFI16 NFATC1 HELZ SKAP2 TCF7L1 ZNF292 | 6.62e-04 | 665 | 128 | 10 | EFO_0007993 |
| Disease | Crohn's disease | 7.01e-04 | 441 | 128 | 8 | EFO_0000384 | |
| Disease | Neurodevelopmental Disorders | 7.32e-04 | 93 | 128 | 4 | C1535926 | |
| Disease | long QT syndrome (implicated_via_orthology) | 8.21e-04 | 10 | 128 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 9.98e-04 | 702 | 128 | 10 | C0009402 | |
| Disease | Microphthalmos | 1.00e-03 | 11 | 128 | 2 | C0026010 | |
| Disease | selective IgA deficiency disease | 1.06e-03 | 46 | 128 | 3 | EFO_1001929 | |
| Disease | cognitive inhibition measurement | 1.35e-03 | 50 | 128 | 3 | EFO_0007969 | |
| Disease | plasma beta-amyloid 1-42 measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0005660 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.41e-03 | 13 | 128 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.41e-03 | 13 | 128 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | hypothyroidism | 1.53e-03 | 284 | 128 | 6 | EFO_0004705 | |
| Disease | ventricular septal defect (is_implicated_in) | 1.64e-03 | 14 | 128 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | asthma | 1.65e-03 | 751 | 128 | 10 | MONDO_0004979 | |
| Disease | intelligence, self reported educational attainment | 1.72e-03 | 117 | 128 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.89e-03 | 15 | 128 | 2 | C2930967 | |
| Disease | response to efavirenz, virologic response measurement | 2.07e-03 | 58 | 128 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | digit length ratio | 2.15e-03 | 16 | 128 | 2 | EFO_0004841 | |
| Disease | Disorder of eye | 2.36e-03 | 212 | 128 | 5 | C0015397 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.43e-03 | 17 | 128 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 2.50e-03 | 62 | 128 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | ANK2 NUP98 GATA3 NUP214 SIK3 ZEB2 STAT4 PER3 FGD5 TCF7L1 CUX1 NLRP8 | 2.52e-03 | 1074 | 128 | 12 | C0006142 |
| Disease | Thyroid preparation use measurement | 2.61e-03 | 217 | 128 | 5 | EFO_0009933 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 2.73e-03 | 18 | 128 | 2 | OBA_2045110 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.74e-03 | 64 | 128 | 3 | DOID:4947 (is_marker_for) | |
| Disease | macrophage inflammatory protein 1b measurement | 2.96e-03 | 136 | 128 | 4 | EFO_0008219 | |
| Disease | anorectal malformation | 3.04e-03 | 19 | 128 | 2 | MONDO_0019938 | |
| Disease | glomerulonephritis (is_marker_for) | 3.04e-03 | 19 | 128 | 2 | DOID:2921 (is_marker_for) | |
| Disease | interstitial lung disease | 3.12e-03 | 67 | 128 | 3 | EFO_0004244 | |
| Disease | renal system measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0004742 | |
| Disease | testosterone measurement | IRF2BP2 HAUS6 ANK2 ANK3 DAG1 IQCN SRCAP ZC3H7A PER3 NFATC1 MYPN SLC24A1 USH2A | 3.67e-03 | 1275 | 128 | 13 | EFO_0004908 |
| Disease | chronic kidney disease | 3.67e-03 | 235 | 128 | 5 | EFO_0003884 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 3.71e-03 | 21 | 128 | 2 | OBA_2045156 | |
| Disease | rheumatoid arthritis | 4.11e-03 | 462 | 128 | 7 | EFO_0000685 | |
| Disease | nasopharyngeal neoplasm | 4.30e-03 | 151 | 128 | 4 | EFO_0004252 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| METKLPPASTPTSPS | 1 | Q15173 | |
| PPSSPVRPMARSSTA | 226 | Q96BA8 | |
| PSESLDPAFSPRMPS | 271 | Q15018 | |
| FTFTVPAMPALTPAP | 301 | Q96HD9 | |
| SLPCHFSTMPTLPPS | 41 | P13611 | |
| SGSMEAPLLSSFLPP | 26 | P0C853 | |
| LSTSPMPTVSSYPPL | 746 | P39880 | |
| MQTDSLSPSPNPVSP | 1 | Q8N9W6 | |
| DSPVPASMFAPEPSS | 11 | O00178 | |
| LKAMVSPFHSPPSTP | 111 | Q6JBY9 | |
| MSTQAFLPSPPLPSD | 1616 | Q13085 | |
| FLPSPPLPSDMLTYT | 1621 | Q13085 | |
| SAPQTPLSPTPMFFP | 466 | O76090 | |
| SPAPTTMDFTPAPLE | 26 | O95388 | |
| TPSPIISPSAMLPIY | 1056 | O75179 | |
| PTSTPAPPEALSSEM | 586 | Q9P1Y5 | |
| PSQPPTLAPTTMATS | 1711 | Q9HC84 | |
| MDPPSPSRTSQTQPT | 1 | Q86YV0 | |
| PQTYPASTMTTTPPK | 351 | Q9H0B3 | |
| PPFQDLPLSSSMTPA | 306 | P14316 | |
| FPFSMPSSLTLPPPE | 541 | O60393 | |
| PSSLTLPPPEDSLFM | 546 | O60393 | |
| VRTMPTSTPAPPSAE | 3306 | Q01484 | |
| PPIAMAATPPASTSS | 76 | Q6NSJ2 | |
| TSVPTPVFPTMDTWP | 891 | Q8WXI7 | |
| ISSPSSPMSTFAIFP | 1476 | Q8WXI7 | |
| PVSSEPSTATSPMVP | 4556 | Q8WXI7 | |
| FSSSLMPSPAMTSPP | 6801 | Q8WXI7 | |
| SVPPPLTSVFTMPSP | 1086 | P52948 | |
| LTSVFTMPSPAPEVP | 1091 | P52948 | |
| NTSDSAMLTPPSSPP | 1446 | Q7RTP6 | |
| PRASLPFPALSMSTT | 1541 | P10071 | |
| ATPMPSRPSTTPFID | 891 | P27816 | |
| APVPTPAMVSAPSST | 446 | Q14244 | |
| FIPMPDSPSPLSAAF | 821 | Q8TD19 | |
| PAMLTTPSPSLTTAL | 401 | O60721 | |
| MALAAPSSPTPESPT | 136 | Q9NQS7 | |
| MSDVNPPSDTPIPFS | 1 | Q86W28 | |
| PPAMASTSLSEAPPF | 436 | Q17R60 | |
| TRIDMIFTPGPPSTP | 566 | O43525 | |
| LAPPTMPTSPSSEQV | 456 | P56696 | |
| TQTPSPAPASDMPRS | 1506 | Q9UPA5 | |
| QTPMPTTQSTLFPVP | 3121 | Q9UPA5 | |
| TPTSPAIAPPTETMA | 341 | Q14118 | |
| DSPDPVHSTPPTTLM | 511 | Q5VYM1 | |
| SSSAPATQFIMLPLP | 276 | Q12766 | |
| PSRMEPPAPLSTSST | 511 | Q8IY33 | |
| SSPTFPPAAMVPSQA | 781 | P56645 | |
| AMSPTLDPPPSVTSQ | 886 | P56645 | |
| RAFAMPAPTPSSSPV | 546 | Q9UBU9 | |
| MPTFPSTEPIYLSLP | 176 | O00443 | |
| LPPAIEMTSTAPPST | 4241 | Q02817 | |
| PSGASPALPIFSMTL | 31 | P34995 | |
| PAYLPRSVPTASMSP | 51 | A6NMT0 | |
| TSTPSSMVDIPPPFD | 606 | Q6ZNL6 | |
| LAPSSPLMYPSPASA | 271 | A8MYZ6 | |
| PLSPTSYMSPTLPAL | 401 | O95644 | |
| TDITPMDPSFATPPR | 901 | Q8IZD2 | |
| SAPNIAMKPSFPPST | 566 | P35658 | |
| APPMSPFSSASKPAA | 606 | P35658 | |
| PSLSPDMPITSTSPV | 491 | Q5JSP0 | |
| LFPDISMTPTIPWSP | 616 | P42694 | |
| MFPSPALTPTPFSVK | 1 | P52952 | |
| SSASPMFKPIFTAPP | 306 | A6NF01 | |
| SPVSSDPVHMSPLEP | 161 | Q9NQX5 | |
| PASIPPEEMSPEFTT | 166 | Q8IZE3 | |
| ASSAPPMFKPIFTAP | 721 | Q96HA1 | |
| PPAPPVRMSSTIFST | 11 | Q13177 | |
| LTTPTPMHPPSSLSF | 416 | P23771 | |
| SGFTTPTAMTPPVLT | 1366 | Q6WRI0 | |
| TIPPFLSSSATLMPV | 1461 | Q6WRI0 | |
| LSSSATLMPVPISPP | 1466 | Q6WRI0 | |
| IMEPTASSVPAPAPT | 341 | Q14209 | |
| MTAFATTPPISSIPP | 246 | P28324 | |
| FLPAPFTSPTEIMPD | 1316 | Q5T9S5 | |
| STATSPFAIMPSSPP | 506 | Q9BQW3 | |
| PFAIMPSSPPLAAAS | 511 | Q9BQW3 | |
| SLPSSTPYTMPPEPT | 986 | O00512 | |
| PSPFSPDASSPLLPM | 1946 | Q9P0X4 | |
| MVSSPPYSLSPRPSV | 266 | Q9NXW2 | |
| SSSMPLSFPSLLPSV | 6 | Q9NWQ9 | |
| VPPHPSSMPVTSSSF | 401 | Q01543 | |
| LKTPQMPPTTPSSSS | 436 | Q6K0P9 | |
| PSPTFMELEPKPTTS | 2196 | Q12955 | |
| FPPPPSASSVSMVQL | 46 | Q6IMN6 | |
| SMAPPTIPSATPATA | 431 | Q04637 | |
| APNMTTLEPTPSPTT | 396 | P07359 | |
| LRTPQMPPTTPSSSF | 426 | Q16666 | |
| PQMPPSTPSSSFLTT | 541 | Q16666 | |
| TPSVDLLPPMSPLSF | 396 | Q7Z4H7 | |
| LLPPMSPLSFDPASE | 401 | Q7Z4H7 | |
| TSFVLPLMPSALPDT | 5456 | Q8NDH2 | |
| MTSESTSPPVVPPLH | 1 | Q9Y534 | |
| SSPTLTSPMEYPSPV | 746 | Q14289 | |
| APPSSVTSTPRTPRM | 366 | Q96DZ5 | |
| TPPAPTSEMVPVISS | 326 | Q9UKT9 | |
| AATPMPTPKSSPFLD | 1081 | O95180 | |
| TVSLVPPAFPVSMPV | 651 | Q9UPN6 | |
| MTPTSSFVSPPPPTA | 391 | Q7Z5L9 | |
| PVFSPPSSIAASMVP | 186 | O75364 | |
| SVSMEVEPSPTSPAP | 61 | Q70SY1 | |
| MTTPSLTPFTPSLVF | 221 | P15407 | |
| MPSFLVPSLVSSPVL | 1 | Q6ZNG9 | |
| EASSPPPTAEVTSMP | 1196 | Q685J3 | |
| TPETPTTQAPPVLMS | 486 | Q9H195 | |
| PMSLPSAFPSSTPVP | 891 | Q8NEY1 | |
| TRPMTTPPTSLPEPF | 91 | Q6ICC9 | |
| PSPPPTKFIVMSSSS | 531 | P49848 | |
| APVFMIPPSVFPLSS | 1361 | O75445 | |
| PPLTAPPTMKSSEFF | 46 | Q684P5 | |
| FPTSSMVDPATGPLL | 236 | Q9H426 | |
| PAAPIPTLSGFSMTL | 381 | Q9UMZ2 | |
| PTLSGFSMTLPTPVS | 386 | Q9UMZ2 | |
| FLTQPHSSMVPPTSP | 161 | Q8WZ73 | |
| MPNPSSTSSPYPLPE | 1 | O75563 | |
| PATTPMPSSSFLPEA | 116 | O95486 | |
| PTPVLSPSSIMLISF | 511 | Q7RTZ1 | |
| ATATTRPSPTTPAMP | 61 | O60292 | |
| PSPLVTMTPAVPAVT | 571 | Q9Y2K2 | |
| APLASTLSPGPMTFS | 196 | Q6ZUB1 | |
| SMTKPPSSEHFPSPQ | 681 | Q8IXF0 | |
| LVTSMPPPVSPSTAA | 86 | Q96M27 | |
| HSSPMPATLSPSTIP | 81 | O75925 | |
| ASSPMPIPNSSPLAS | 1411 | Q6ZRS2 | |
| PTPVLAPSSTQTMLP | 1651 | Q6ZRS2 | |
| APSSTQTMLPAPVPS | 1656 | Q6ZRS2 | |
| THSTMIPDPTTTPQP | 1191 | A1L4H1 | |
| HSTMIPDPTTTPQPF | 1211 | A1L4H1 | |
| TPQPFTTMQPTTTPH | 1221 | A1L4H1 | |
| THSTMIPDPTTTPQP | 1251 | A1L4H1 | |
| TPMTTQPPNPTFSLL | 286 | A8K7I4 | |
| MPSNTTPEPAPTPTV | 276 | Q96F05 | |
| SIMPPLAPTSAPADT | 231 | Q8N5U0 | |
| PMQTPTSSPPSFEFK | 786 | Q9UPV9 | |
| MPLFLLSLPTPPSAS | 1 | Q5M7Z0 | |
| LFSPLSSSPTPMTIC | 441 | Q96F44 | |
| SSSMEPTAPLVTPPP | 241 | Q9Y2W6 | |
| KLSDPPTSPSSPSQM | 581 | Q13496 | |
| MPTALLASPPSFPAT | 551 | Q9HCS4 | |
| PHSPSDLLPMSPSVY | 711 | Q14765 | |
| LPDSSPFSSFISVMP | 1806 | O60281 | |
| RPVFTSPTPAMAAVP | 116 | Q53EL9 | |
| MPPTASLTRSPPTAS | 1 | A8MUU9 | |
| SSSPPRASPVRMAPS | 406 | Q9Y2K6 | |
| MSSLPVPYTLPVSLP | 1 | Q8TCE9 | |
| SPSMPFSASLLGTLP | 316 | Q8IWR0 | |
| PDLHSPMSPISESPS | 401 | Q8N5H7 | |
| PMSPISESPSSPAYS | 406 | Q8N5H7 | |
| PEPSTAPSTSFLLPM | 231 | P20333 | |
| TALPPQSAFPPATFM | 896 | O60315 | |
| MSPTPPLFSLPEART | 1 | Q96FV9 | |
| TMPAPPTTTSAFVEL | 1841 | Q9UKN1 | |
| SMPSRPFVPLAVTSP | 706 | Q00872 | |
| PPSSPKEFPFSMTVL | 681 | Q86TC9 |